Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in korean men: 5-year prospective cohort study

被引:137
作者
Park, Sung Keun [1 ]
Seo, Mi Hae [2 ]
Shin, Ho Cheol [3 ]
Ryoo, Jae-Hong [4 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Total Healthcare Ctr, Kangbuk Samsung Hosp, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Dept Internal Med, Kangbuk Samsung Hosp, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Dept Family Med, Kangbuk Samsung Hosp, Seoul, South Korea
[4] Kyung Hee Univ, Dept Prevent Med, Sch Med, Seoul 130701, South Korea
关键词
BETA-CELL FUNCTION; INSULIN-RESISTANCE; PREVALENCE; GLUCOSE;
D O I
10.1002/hep.26183
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
There have been several reports about the clinical association between type 2 diabetes mellitus (DM) and nonalcoholic fatty liver disease (NAFLD). However, most of the studies were about the unilateral effects of type 2 DM on NAFLD, and studies on the reverse relation are rare. Thus, this study was designed to investigate the effect of NAFLD on type 2 DM. We conducted a prospective cohort study on 25,232 Korean men without type 2 DM for 5 years. We serially checked the various metabolic factors including fasting glucose and hemoglobin A1c (HbA1c), and monitored the development of type 2 DM. The incidence rate of type 2 DM was compared according to the degree of NAFLD (normal, mild, and moderate to severe), and a Cox proportional hazards model was used to measure the hazard ratios (HRs) of NAFLD on type 2 DM. The incidence rate of type 2 DM increased according to the degree of NAFLD (normal: 7.0%, mild: 9.8%, moderate to severe: 17.8%, P < 0.001). Even after adjusting for other multiple covariates, the HRs (95% confidence interval [CI]) for type 2 DM development was higher in the mild group (1.09; 0.81-1.48) and moderate to severe group (1.73; 1.00-3.01) compared to the normal group, respectively (P for trend <0.001). Conclusion: The development of type 2 DM is potentially more associated with more progressive NAFLD than a normal or milder state. In addition, NAFLD was an independent risk factor for the future development of type 2 DM. These results suggest the potential availability of NAFLD as an early predictor of type 2 DM. (HEPATOLOGY 2013;57:13781383)
引用
收藏
页码:1378 / 1383
页数:6
相关论文
共 20 条
[1]   The metabolic syndrome - a new worldwide definition [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
LANCET, 2005, 366 (9491) :1059-1062
[2]  
Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI [10.2337/dc10-S062, 10.2337/dc14-S081, 10.2337/dc11-S011, 10.2337/dc13-S011, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062, 10.2337/dc10-S011, 10.2337/dc12-s011]
[3]   Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance [J].
An, J ;
Muoio, DM ;
Shiota, M ;
Fujimoto, Y ;
Cline, GW ;
Shulman, GI ;
Koves, TR ;
Stevens, R ;
Millington, D ;
Newgard, CB .
NATURE MEDICINE, 2004, 10 (03) :268-274
[4]   Combined Effect of Nonalcoholic Fatty Liver Disease and Impaired Fasting Glucose on the Development of Type 2 Diabetes A 4-year retrospective longitudinal study [J].
Bae, Ji Cheol ;
Rhee, Eun Jung ;
Lee, Won Young ;
Park, Se Eun ;
Park, Cheol Young ;
Oh, Ki Won ;
Park, Sung Woo ;
Kim, Sun Woo .
DIABETES CARE, 2011, 34 (03) :727-729
[5]   Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos Nutrition and Liver Study [J].
Bedogni, G ;
Miglioli, L ;
Masutti, F ;
Tiribelli, C ;
Marchesini, G ;
Bellentani, S .
HEPATOLOGY, 2005, 42 (01) :44-52
[6]   Nonalcoholic fatty liver disease and vascular risk [J].
Bhatia, Lokpal S. ;
Curzen, Nicholas P. ;
Byrne, Christopher D. .
CURRENT OPINION IN CARDIOLOGY, 2012, 27 (04) :420-428
[7]   Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms [J].
Bugianesi, E ;
Gastaldelli, A ;
Vanni, E ;
Gambino, R ;
Cassader, M ;
Baldi, S ;
Ponti, V ;
Pagano, G ;
Ferrannini, E ;
Rizzetto, M .
DIABETOLOGIA, 2005, 48 (04) :634-642
[8]   Alanine aminotransferase, γ-glutamyltransferase (GGT) and all-cause mortality: results from a population-based Danish twins study alanine aminotransferase, GGT and mortality in elderly twins [J].
Fraser, Abigail ;
Thinggaard, Mikael ;
Christensen, Kaare ;
Lawlor, Debbie A. .
LIVER INTERNATIONAL, 2009, 29 (10) :1494-1499
[9]   Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects [J].
Gastaldelli, Amalia ;
Cusi, Kenneth ;
Pettiti, Maura ;
Hardies, Jean ;
Miyazaki, Yoshinori ;
Berria, Rachele ;
Buigoli, Emma ;
Sironi, Anna Maria ;
Cersosimo, Eugenio ;
Ferrannini, Ele ;
Defronzo, Ralph A. .
GASTROENTEROLOGY, 2007, 133 (02) :496-506
[10]   Diagnosis of fatty liver disease: is biopsy necessary.? [J].
Joy, D ;
Thava, VR ;
Scott, BB .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2003, 15 (05) :539-543